CareFirst Prescription Drug Program

Sample Notes Page - CareFirst BlueCross BlueShield

Members & Visitors

Print
Close

Prescription Drug Database

To expand a category or sub-category, click on the

to its left.

Category

Blood

Cancer Drugs-Other (Antineoplastics)

Cancer Drugs -Oral (Antineoplastics)

Central Nervous System

Chest pain & heart disease

Diabetes & high blood sugar

Diseases

ENT (Ear/Nose/Throat)

Eye

Heart rhythm disorders

High blood pressure & heart disease

High cholesterol drugs (antilipemics)

HIV & AIDS

Hormones

Immune system

Infections

Mental health

Miscellaneous drugs

Muscle relaxers

Narcolepsy

OB-GYN

Pain management (analgesics)

Pain management (Cox 2)

Respiratory problems

Skin

acne

anti-inflammatory or corticosteroids

debriedment agent

diseases-eczema & psoriasis

genital warts

lice and scabies treatment

miscellaneous

Brand Name (Tier 3): EFUDEX

Generic Name (Tier 1): fluorouracil

Brand Name (Tier 3): OXSORALEN

Generic Not Available

Brand Name (Tier 3): PANRETIN

Generic Not Available

Brand Name (Tier 3): PENLAC

Generic Name (Tier 1): ciclopirox

Brand Name (Tier 3): SORIATANE

Generic Not Available

Brand Not Available

Generic Not Available

topical antibiotics

topical antifungal drugs

Steroids (oral anti-inflammatory drugs)

Stomach & Digestive disorders

Substance abuse

Supplements

Urology

Print
Close

HIPAA
Report Fraud
Privacy Statement
Site Map
Site Survey

Serving Maryland, the District of Columbia and portions of Virginia. CareFirst BlueCross BlueShield is the shared
business name of CareFirst of Maryland, Inc. and Group Hospitalization and Medical Services, Inc. CareFirst BlueChoice, Inc.,
an affiliate company, also offers health benefit products and services on this site.

CareFirst BlueCross BlueShield and CareFirst BlueChoice, Inc. are independent licensees of the Blue Cross and Blue Shield Association.

® Registered trademark of the Blue Cross and Blue Shield Association. ®' Registered trademark of CareFirst of Maryland, Inc.

This site is best viewed in IE 7.0 or IE 8.0 or Firefox 3.0.